Searle & Co’s Gilead Sciences GILD Stock Holding History

Searle & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Hold	2,050	–	–	0.06%	173
2026 Q1	$286K	Hold	2,050	–	–	0.07%	160
2025 Q4	$252K	Hold	2,050	–	–	0.06%	167
2025 Q3	$228K	Hold	2,050	–	–	0.06%	173
2025 Q2	$227K	Hold	2,050	–	–	0.06%	163
2025 Q1	$230K	Buy	+2,050	New	+$212K	0.07%	162
2024 Q3	–	Sell	-6,750	Closed	-$463K	–	180
2024 Q2	$463K	Buy	6,750 +2,700	+67%	+$180K	0.11%	113
2024 Q1	$297K	Hold	4,050	–	–	0.08%	128
2023 Q4	$328K	Buy	+4,050	New	+$315K	0.09%	123
2021 Q1	–	Sell	-5,500	Closed	-$320K	–	143
2020 Q4	$320K	Buy	5,500 +1,300	+31%	+$78.4K	0.15%	107
2020 Q3	$265K	Buy	+4,200	New	+$291K	0.14%	111
2018 Q2	–	Sell	-13,200	Closed	-$995K	–	133
2018 Q1	$995K	Hold	13,200	–	–	0.65%	50
2017 Q4	$946K	Sell	13,200 -150	-1%	-$11.4K	0.59%	55
2017 Q3	$1.08M	Hold	13,350	–	–	0.72%	51
2017 Q2	$945K	Hold	13,350	–	–	0.65%	53
2017 Q1	$907K	Buy	13,350 +80	+0.6%	+$5.63K	0.64%	52
2016 Q4	$950K	Sell	13,270 -1,300	-9%	-$96.6K	0.79%	46
2016 Q3	$1.13M	Buy	+14,570	New	+$1.18M	0.98%	38
2016 Q2	–	Sell	-14,570	Closed	-$1.37M	–	55
2016 Q1	$1.37M	Buy	14,570 +220	+2%	+$19.8K	1.26%	27
2015 Q4	$1.41M	Hold	14,350	–	–	1.35%	21
2015 Q3	$1.41M	Hold	14,350	–	–	1.45%	16
2015 Q2	$1.68M	Hold	14,350	–	–	1.4%	16
2015 Q1	$1.41M	Sell	14,350 -50	-0.3%	-$5.08K	1.21%	22
2014 Q4	$1.36M	Buy	+14,400	New	+$1.49M	1.15%	22

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Searle & Co's GILD Position: Q2 2026 in Review

Searle & Co held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,050 shares worth $259K. The position accounts for 0.06% of the portfolio, ranked #173.

Searle & Co first reported a position in GILD in Q4 2014 and has held it in 24 quarters since. The position peaked at $1.68M in Q2 2015. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Searle & Co held 2,050 shares of Gilead Sciences worth $259K as of Q2 2026.
Searle & Co left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.06% of Searle & Co's portfolio in Q2 2026, its #173 holding.
Searle & Co first reported a position in Gilead Sciences in Q4 2014 and has held it in 24 quarters since.
Searle & Co's Gilead Sciences position peaked at $1.68M in Q2 2015.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.